cas 1094073-72-9|| where to buy 4,4-difluoroazepane

Nombre del producto:4,4-difluoroazepane

IUPAC Name:4,4-difluoroazepane

Unidad de embalaje	Stock disponible	Precio($)
CM104894-100mg	in stock	ƥŉǵ
CM104894-250mg	in stock	Źůŉ
CM104894-1g	3-4 Weeks	ƥŗŹƥ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1094073-72-9 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1094073-72-9; Fórmula molecular:C6H11F2N; Punto de fusión:-; Código de sonrisas:FC1(F)CCNCCC1; Densidad:

: Número de catálogo:CM104894; Peso molecular:135.16; Punto de ebullición:; Nº Mdl:MFCD11870210; Almacenamiento:

: Fluorinated Compounds; Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.

: Azepanes; The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.

: Alicyclic Heterocycles; When the ends of the chains are joined together into a ring, cyclic compounds result; such substances often are referred to as carbocyclic or alicyclic compounds. Substitution of one or more of the ring carbon atoms in the molecules of a carbocyclic compound with a heteroatom gives a heterocyclic compound.

: Fluorinated compounds; Fluorinated compounds refers to organic or inorganic compounds containing fluorine.